Iambic Therapeutics issued approximately 16 USD shares at a per-share price of 9380000, in the United States IPO IPO 150000000 USD, and is expected to trade on Nasdaq on October 15 under the ticker IAM.
According to Bloomberg,OPay plans to raise funds through the New York IPO and concurrent private placement, totaling approximately 500000000 USD with Standard Bank Group expected to participate in approximately 200000000 USD in the private placement. The plan has not been publicly disclosed.
